Omeicos Therapeutics GMBH
omeicos.comOmeicos Therapeutics has discovered a series of metabolically robust synthetic analogues of omega-3 fatty acid-derived epoxyeicosanoids that have the potential to treat mitochondrial dysfunction, inflammatory, cardiovascular, and other diseases. Epoxyeicosanoids activate cell type-specific endogenous pathways that promote organ and tissue protection. Omeicos’ small molecules are orally available and show improved biological activity and pharmacokinetic properties compared to their natural counterparts. The currently active PMD-Option Phase 2a clinical study is evaluating Omeicos’ lead development program OMT-28 in patients with primary mitochondrial disease.
Something looks off?Open jobs at Omeicos Therapeutics GMBH
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.